Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
0143-9519-10 · Methotrexate Sodium Injection · Hikma Pharmaceuticals USA, Inc.
What is the package ndc for 0143-9519-10 · Methotrexate Sodium Injection · Hikma Pharmaceuticals USA, Inc.?
For 0143-9519-10 · Methotrexate Sodium Injection · Hikma Pharmaceuticals USA, Inc., package ndc is 0143-9519-10; generic name is Methotrexate Sodium Injection; manufacturer is Hikma Pharmaceuticals USA, Inc; status is Current; availability now is Available, recorded from its source on 2026-09-01.
"initial_posting_date": "03/13/2023", "package_ndc": "0143-9519-10", "generic_name": "Methotrexate Sodium Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released."
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 0143-9519-10 verified
- Generic name
- Methotrexate Sodium Injection verified
- Manufacturer
- Hikma Pharmaceuticals USA, Inc. verified
- Status
- Current verified
- Availability now
- Available verified
- FDA note
- Additional lots are scheduled to be manufactured. Product will be made available as it is released. verified
- Initial posting date
- 03/13/2023 verified
- Last update date
- 08/13/2026 verified
- Days in shortage
- 1268 our reading
- Dosage form
- Injection verified
- Therapeutic category
- Rheumatology verified
- Reason for shortage
- Demand increase for the drug also on this page
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Dosage form and Therapeutic category
"update_date": "08/13/2026", "therapeutic_category": [ "Rheumatology", "Oncology" ], "dosage_form": "Injection", "presentation": "Methotrexate, Preservative Free, Injection, 25 mg/1 mL (NDC 0143-9519-10)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
The same source also states
"initial_posting_date": "03/13/2023", "package_ndc": "0143-9519-10", "generic_name": "Methotrexate Sodium Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released."
— api.fda.gov, retrieved 2026-09-07
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000